Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-03-14

Clinical Trial Update: Study Evaluating the Efficacy and Safety With CAR-T for Relapsed or Refractory Neuroblastoma in Children [NA]

View source ↗

Summary

This document reports a clinical trial evaluating the efficacy and safety of CAR-T therapy in children with relapsed or refractory neuroblastoma. Status of the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sinobioway Cell Therapy Co., Ltd. | Conditions: Relapsed or Refractory Neuroblastoma | NA | Status: UNKNOWN